Cargando…
The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs
Swine vesicular disease virus (SVDV) is a porcine pathogen and a member of the species Enterovirus B within the Picornaviridae family. Brefeldin A (BFA) is an inhibitor of guanine nucleotide exchange factors of Arf proteins that induces Golgi complex disassembly and alters the cellular secretory pat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846857/ https://www.ncbi.nlm.nih.gov/pubmed/27199941 http://dx.doi.org/10.3389/fmicb.2016.00612 |
_version_ | 1782429116106014720 |
---|---|
author | Vázquez-Calvo, Ángela Caridi, Flavia González-Magaldi, Mónica Saiz, Juan-Carlos Sobrino, Francisco Martín-Acebes, Miguel A. |
author_facet | Vázquez-Calvo, Ángela Caridi, Flavia González-Magaldi, Mónica Saiz, Juan-Carlos Sobrino, Francisco Martín-Acebes, Miguel A. |
author_sort | Vázquez-Calvo, Ángela |
collection | PubMed |
description | Swine vesicular disease virus (SVDV) is a porcine pathogen and a member of the species Enterovirus B within the Picornaviridae family. Brefeldin A (BFA) is an inhibitor of guanine nucleotide exchange factors of Arf proteins that induces Golgi complex disassembly and alters the cellular secretory pathway. Since BFA has been shown to inhibit the RNA replication of different enteroviruses, including SVDV, we have analyzed the effect of BFA and of golgicide A (GCA), another Golgi disrupting drug, on SVDV multiplication. BFA and GCA similarly inhibited SVDV production. To investigate the molecular basis of the antiviral effect of BFA, SVDV mutants with increased resistance to BFA were isolated. A single amino acid substitution, Q65H, in the non-structural protein 2C was found to be responsible for increased resistance to BFA. These results provide new insight into the relationship of enteroviruses with the components of the secretory pathway and on the role of SVDV 2C protein in this process. |
format | Online Article Text |
id | pubmed-4846857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-48468572016-05-19 The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs Vázquez-Calvo, Ángela Caridi, Flavia González-Magaldi, Mónica Saiz, Juan-Carlos Sobrino, Francisco Martín-Acebes, Miguel A. Front Microbiol Microbiology Swine vesicular disease virus (SVDV) is a porcine pathogen and a member of the species Enterovirus B within the Picornaviridae family. Brefeldin A (BFA) is an inhibitor of guanine nucleotide exchange factors of Arf proteins that induces Golgi complex disassembly and alters the cellular secretory pathway. Since BFA has been shown to inhibit the RNA replication of different enteroviruses, including SVDV, we have analyzed the effect of BFA and of golgicide A (GCA), another Golgi disrupting drug, on SVDV multiplication. BFA and GCA similarly inhibited SVDV production. To investigate the molecular basis of the antiviral effect of BFA, SVDV mutants with increased resistance to BFA were isolated. A single amino acid substitution, Q65H, in the non-structural protein 2C was found to be responsible for increased resistance to BFA. These results provide new insight into the relationship of enteroviruses with the components of the secretory pathway and on the role of SVDV 2C protein in this process. Frontiers Media S.A. 2016-04-27 /pmc/articles/PMC4846857/ /pubmed/27199941 http://dx.doi.org/10.3389/fmicb.2016.00612 Text en Copyright © 2016 Vázquez-Calvo, Caridi, González-Magaldi, Saiz, Sobrino and Martín-Acebes. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Vázquez-Calvo, Ángela Caridi, Flavia González-Magaldi, Mónica Saiz, Juan-Carlos Sobrino, Francisco Martín-Acebes, Miguel A. The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs |
title | The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs |
title_full | The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs |
title_fullStr | The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs |
title_full_unstemmed | The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs |
title_short | The Amino Acid Substitution Q65H in the 2C Protein of Swine Vesicular Disease Virus Confers Resistance to Golgi Disrupting Drugs |
title_sort | amino acid substitution q65h in the 2c protein of swine vesicular disease virus confers resistance to golgi disrupting drugs |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846857/ https://www.ncbi.nlm.nih.gov/pubmed/27199941 http://dx.doi.org/10.3389/fmicb.2016.00612 |
work_keys_str_mv | AT vazquezcalvoangela theaminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs AT caridiflavia theaminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs AT gonzalezmagaldimonica theaminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs AT saizjuancarlos theaminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs AT sobrinofrancisco theaminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs AT martinacebesmiguela theaminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs AT vazquezcalvoangela aminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs AT caridiflavia aminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs AT gonzalezmagaldimonica aminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs AT saizjuancarlos aminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs AT sobrinofrancisco aminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs AT martinacebesmiguela aminoacidsubstitutionq65hinthe2cproteinofswinevesiculardiseasevirusconfersresistancetogolgidisruptingdrugs |